NeuroBo Pharmaceuticals, Inc.
USD2.36
CEO
Hyung-Heon Kim
IPO Date
2016-08-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Day Low
$2.36
Day High
$2.36
52W Low
$2.36
52W High
$2.36
Market Cap
$0.02B
| -0.6 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -74.7% | -54.7% | 0.01 | 3.78 | -1.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -64.2% | -41.7% | 0.00 | 2.85 | -0.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -104.7% | -91.0% | 0.00 | 7.69 | -0.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -412.0% | -270.6% | 0.01 | 2.89 | -0.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -173.4% | -147.3% | 0.01 | 6.78 | -0.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 116.9% | -406.5% | -0.72 | 17.39 | -0.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -847.9% | -175.7% | 2.55 | 2.97 | -0.0 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -70.7% | -58.9% | 0.00 | 6.00 | -0.0 |
| -2.5 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -53.3% | -22.9% | 0.01 | 1.74 | -1.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -41.5% | -21.6% | 0.01 | 2.08 | -0.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -83.8% | -30.3% | 0.03 | 1.55 | -1.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -65.2% | -31.8% | 0.02 | 1.94 | -0.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -43.6% | -25.5% | 0.01 | 2.41 | -1.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -53.1% | -35.0% | 0.01 | 2.94 | -0.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -66.6% | -39.5% | 0.02 | 2.46 | -0.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -31.8% | -23.3% | 0.01 | 3.78 | -0.6 |